Movement Disorders · 2007 · 155 citations · 44 references
MedicineNeurologyPsychiatryMental Health In Older AdultsMovement DisordersPhysical DisabilitiesDisability EvaluationHealth-related Quality Of LifeHealth-related Quality Of Life MeasurementParkinson DiseaseParkinsonian DisordersDisability Severity MeasurementDisease SymptomatologyMotor Impairment AssessmentMovement Disorder AssessmentNeurodegenerative Disease Symptom BurdenPhysical Health ConditionQuality Of Life Impairment
Psychogenic movement disorders are associated with severe impairment, yet their effects on disability and quality of life have not been studied. The study compared 66 PMD patients with 704 Parkinson’s disease patients using disability, quality‑of‑life, and psychiatric symptom measures. PMD patients exhibited disability comparable to Parkinson’s disease, similar physical quality of life but significantly poorer mental health, and higher psychiatric distress, indicating that psychogenic movement disorders impose disability and mental‑health burdens comparable to a progressive neurodegenerative condition. © 2007 Movement Disorder Society.
Abstract Patients with psychogenic movement disorders (PMD) often report severe impairment, yet the impact of PMD on disability and quality of life has not been examined. We compared 66 patients with PMD and 704 patients with Parkinson's disease (PD) on measures of disability (Older Americans Resources and Services Scale, OARS); quality of life (QOL; SF‐12v2 Health Survey) and psychiatric symptomatology (Brief Symptom Inventory 18, BSI‐18). On the total OARS, PMD and PD patients reported similar levels of disability (17.6 ± 6.6, 19.8 ± 10.9, P = 0.490 at “best” function and 24.1 ± 11.2, 26.2 ± 14.3, P = 0.497 at their “worst” function). PMD patients reported similar Physical Health QOL to PD patients (38.9 ± 14.5, 39.8 ± 11.6, P = 0.652) but worse mental health QOL (41.6 ± 13.4 vs. 48.9 ± 11.0, P < 0.001). On the BSI‐18, PMD patients reported higher levels of distress on the Global Symptom Index (62.03 ± 9.6 vs. 53.7 ± 9.9, P < 0.001) and on Anxiety, Depression and Somatization subscales (PMD vs. PD scores: Anxiety 58.9 ± 12.0 vs. 52.3 ± 10.1, P < 0.001; Depression 58.8 ± 11.9 vs. 51.3 ± 10.3, P < 0.001; Somatization 60.5 ± 11.0 vs. 54.7 ± 8.7, P < 0.001). Thus, severity of disability reported by the PMD group was equal to that seen in a progressive neurodegenerative condition. Quality of life and mental health implications of PMD were also evident. PMD impacts several aspects of patient function and daily life. © 2007 Movement Disorder Society
44
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
Cross-National Epidemiology of Major Depression and Bipolar Disorder
Myrna M. Weissman · JAMA · 1996 · 2.2K citations
High levels of untreated distress and fatigue in cancer patients
Linda E. Carlson, Maureen Angen, Jodi Cullum et al. · British Journal of Cancer · 2004 · 941 citations · Full text
Somatoform disorders in general practice
Margot W. M. de Waal, Ingrid Arnold, Just Eekhof et al. · The British Journal of Psychiatry · 2004 · 533 citations · Full text